Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs - PubMed (original) (raw)
. 2015 Nov 11;15(11):7300-6.
doi: 10.1021/acs.nanolett.5b02497. Epub 2015 Oct 20.
Affiliations
- PMID: 26469188
- DOI: 10.1021/acs.nanolett.5b02497
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
Kevin J Kauffman et al. Nano Lett. 2015.
Abstract
Intracellular delivery of messenger RNA (mRNA) has the potential to induce protein production for many therapeutic applications. Although lipid nanoparticles have shown considerable promise for the delivery of small interfering RNAs (siRNA), their utility as agents for mRNA delivery has only recently been investigated. The most common siRNA formulations contain four components: an amine-containing lipid or lipid-like material, phospholipid, cholesterol, and lipid-anchored polyethylene glycol, the relative ratios of which can have profound effects on the formulation potency. Here, we develop a generalized strategy to optimize lipid nanoparticle formulations for mRNA delivery to the liver in vivo using Design of Experiment (DOE) methodologies including Definitive Screening and Fractional Factorial Designs. By simultaneously varying lipid ratios and structures, we developed an optimized formulation which increased the potency of erythropoietin-mRNA-loaded C12-200 lipid nanoparticles 7-fold relative to formulations previously used for siRNA delivery. Key features of this optimized formulation were the incorporation of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and increased ionizable lipid:mRNA weight ratios. Interestingly, the optimized lipid nanoparticle formulation did not improve siRNA delivery, indicating differences in optimized formulation parameter design spaces for siRNA and mRNA. We believe the general method described here can accelerate in vivo screening and optimization of nanoparticle formulations with large multidimensional design spaces.
Keywords: Lipid nanoparticle; design of experiment; in vivo; mRNA; nucleic acid.
Similar articles
- PEGylated lipid screening, composition optimization, and structure-activity relationship determination for lipid nanoparticle-mediated mRNA delivery.
Liu L, Kim JH, Li Z, Sun M, Northen T, Tang J, Mcintosh E, Karve S, DeRosa F. Liu L, et al. Nanoscale. 2025 May 9;17(18):11329-11344. doi: 10.1039/d5nr00433k. Nanoscale. 2025. PMID: 40131321 - Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K, Sundaresan A, Cheow WS. Hadinoto K, et al. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Eur J Pharm Biopharm. 2013. PMID: 23872180 Review. - Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL, Hajj KA, Vizelman J, Bajaj P, Whitehead KA. Ball RL, et al. Nano Lett. 2018 Jun 13;18(6):3814-3822. doi: 10.1021/acs.nanolett.8b01101. Epub 2018 May 8. Nano Lett. 2018. PMID: 29694050 - Preparation and Optimization of Lipid-Like Nanoparticles for mRNA Delivery.
Li B, Dong Y. Li B, et al. Methods Mol Biol. 2017;1632:207-217. doi: 10.1007/978-1-4939-7138-1_13. Methods Mol Biol. 2017. PMID: 28730441 Free PMC article. - Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Qiu M, Li Y, Bloomer H, Xu Q. Qiu M, et al. Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20. Acc Chem Res. 2021. PMID: 34668716 Review.
Cited by
- Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver.
Kim M, Jeong M, Hur S, Cho Y, Park J, Jung H, Seo Y, Woo HA, Nam KT, Lee K, Lee H. Kim M, et al. Sci Adv. 2021 Feb 26;7(9):eabf4398. doi: 10.1126/sciadv.abf4398. Print 2021 Feb. Sci Adv. 2021. PMID: 33637537 Free PMC article. - Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment.
Huang Y, Guo X, Wu Y, Chen X, Feng L, Xie N, Shen G. Huang Y, et al. Signal Transduct Target Ther. 2024 Feb 21;9(1):34. doi: 10.1038/s41392-024-01745-z. Signal Transduct Target Ther. 2024. PMID: 38378653 Free PMC article. Review. - Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material.
Tanaka H, Takata N, Sakurai Y, Yoshida T, Inoue T, Tamagawa S, Nakai Y, Tange K, Yoshioka H, Maeki M, Tokeshi M, Akita H. Tanaka H, et al. Pharmaceutics. 2021 Apr 13;13(4):544. doi: 10.3390/pharmaceutics13040544. Pharmaceutics. 2021. PMID: 33924589 Free PMC article. - Lipid Nanoparticle Delivery System for mRNA Encoding B7H3-redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors.
Huang C, Duan X, Wang J, Tian Q, Ren Y, Chen K, Zhang Z, Li Y, Feng Y, Zhong K, Wang Y, Zhou L, Guo G, Song X, Tong A. Huang C, et al. Adv Sci (Weinh). 2023 Jan;10(3):e2205532. doi: 10.1002/advs.202205532. Epub 2022 Nov 20. Adv Sci (Weinh). 2023. PMID: 36403209 Free PMC article. - Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates.
Suzuki Y, Miyazaki T, Muto H, Kubara K, Mukai Y, Watari R, Sato S, Kondo K, Tsukumo SI, Yasutomo K, Ito M, Tsukahara K. Suzuki Y, et al. Mol Ther Nucleic Acids. 2022 Dec 13;30:226-240. doi: 10.1016/j.omtn.2022.09.017. Epub 2022 Sep 24. Mol Ther Nucleic Acids. 2022. PMID: 36187052 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources